EUCTR2015-003412-20-ES进行中（未招募）1 期
Efficacy and safety of hourly titrated misoprostol versus vaginal dinoprostone and misoprostol for cervical ripening and labor induction: randomized clinical trial. - DV-MV-MO
Basque Health System0 个研究点开始时间: 2016年1月13日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •? Women over 18
- •? single pregnancy
- •? cephalic presentation
- •? intact membranes
- •? unfavorable cervix ( less than 6 Bishop )
- •? CTGR not reactive decelerative
- •? Signed informed consent by the patient.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 372
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •? prior Cesarean section or previous uterine surgery .
- •? Allergy or intolerance to any of the study drugs
- •? stillbirth
- •? uterine growth restricted fetuses
- •? contraindication for vaginal delivery
- •? Anterior placenta
- •? Multiparity
- •? moderate to severe heart disease
- •? hypertensive disorders of pregnancy
- •? Suspected chorioamnionitis
研究者
相似试验
已完成
不适用
Misoprostol mifepristone for termination of pregnancyabortionCTRI/2011/07/001894Indian Council Of Medial Research200
Unknown
4 期
Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor InductionLabor, InducedNCT02902653Oihane Lapuente Ocamica372
已完成
不适用
Evaluation of Effectiveness of Misoprostol in Office Hysteroscopy : A Prospective Randomized Double Blind Placebo Controlled TrialCTRI/2019/04/018458All India Institute of Medical Sciences New Delhi100
招募中
不适用
Addition of 400 microgram misoprotol to routine management of third stage of labour in women at risk for bleeding after delivery.CTRI/2014/03/004491RS MEDICAL COLLEGE KOLKATA200
已完成
4 期
misoprostol efficiency in postpartum hemorrhage.postpartum hemorrhagePACTR201812901591120400